Division of Marine Biotechnology, Institute of Oceanography, University of Gdańsk, Marszałka Józefa Piłsudskiego 46, PL-81378 Gdynia, Poland.
Department of Biomedical Chemistry, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, PL-80308 Gdańsk, Poland.
Biomolecules. 2021 Oct 8;11(10):1483. doi: 10.3390/biom11101483.
Nostocyclopeptides (Ncps) are a small class of bioactive nonribosomal peptides produced solely by cyanobacteria of the genus . In the current work, six Ncps were isolated from strain CCNP1411. The bioactivity of these compounds was tested in vitro against 20S proteasome, a proteolytic complex that plays an important role in maintaining cellular proteostasis. Dysfunction of the complex leads to many pathological disorders. The assays indicated selective activity of specific Ncp variants. For two linear peptide aldehydes, Ncp-A2-L and Ncp-E2-L, the inhibitory effects on chymotrypsin-like activity were revealed, while the cyclic variant, Ncp-A2, inactivated the trypsin-like site of this enzymatic complex. The aldehyde group was confirmed to be an important element of the chymotrypsin-like activity inhibitors. The nostocyclopeptides, as novel inhibitors of 20S proteasome, increased the number of natural products that can be considered potential regulators of cellular processes.
Nostocyclopeptides (Ncps) 是一类由蓝藻属 产生的具有生物活性的非核糖体肽。在本研究中,从 菌株 CCNP1411 中分离出 6 种 Nostocyclopeptides。这些化合物的生物活性在体外通过 20S 蛋白酶体进行了测试,20S 蛋白酶体是一种在维持细胞蛋白质平衡中起重要作用的蛋白水解复合物。该复合物功能失调会导致多种病理紊乱。结果表明,特定的 Ncp 变体具有选择性活性。对于两种线性肽醛,Ncp-A2-L 和 Ncp-E2-L,揭示了对糜蛋白酶样活性的抑制作用,而环状变体 Ncp-A2 则使该酶复合物的胰蛋白酶样位点失活。醛基被确认为糜蛋白酶样活性抑制剂的重要组成部分。 Nostocyclopeptides 作为 20S 蛋白酶体的新型抑制剂,增加了可被视为细胞过程潜在调节剂的天然产物的数量。